title: Adenosine receptor crossroads in sickle cell disease.
authors.forename: Mark T
authors.initials: MT
authors.lastname: Gladwin
mesh_terms: D000241:Adenosine / Q000502:physiology / Q000627:therapeutic use; D000255:Adenosine Triphosphate / Q000378:metabolism; D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology; D006451:Hemoglobin, Sickle / Q000378:metabolism; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008822:Mice, Transgenic; D017354:Point Mutation; D043705:Receptor, Adenosine A2A / Q000502:physiology; D043704:Receptor, Adenosine A2B / Q000502:physiology; D018047:Receptors, Purinergic P1 / Q000502:physiology / Q000627:therapeutic use*; D015398:Signal Transduction; D055544:beta-Globins / Q000235:genetics
chemical_list: D006451:Hemoglobin, Sickle; D043705:Receptor, Adenosine A2A; D043704:Receptor, Adenosine A2B; D018047:Receptors, Purinergic P1; D055544:beta-Globins; D000255:Adenosine Triphosphate; D000241:Adenosine